Navigation Links
Stifled Anger at Work Doubles Men's Risk for Heart Attack
Date:11/23/2009

More open on-the-job interaction might ease the problem, researchers say

MONDAY, Nov. 23 (HealthDay News) -- Men who bottle up their anger over unfair treatment at work could be hurting their hearts, a new Swedish study indicates.

Men who consistently failed to express their resentment over conflicts with a fellow worker or supervisor were more than twice as likely to have a heart attack or die of heart disease as those who vented their anger, claims a report in the Nov. 24 online edition of the Journal of Epidemiology and Community Health.

In fact, ignoring an ongoing work-related conflict was associated with a tripled risk of heart attack or coronary death, the study of almost 2,800 Swedish working men found.

"It is not good just to walk away after having such a conflict or to swallow one's feelings," said study co-author Constanze Leineweber, a psychologist at Stockholm University's Stress Research Institute.

The study did not specify good ways of coping with work-related stress -- "We just looked at the bad side of coping," Leineweber explained.

The study doesn't advocate being belligerent at work, Leineweber cautioned. "Shouting out, and so on, is not proper coping," she said.

But venting one's anger outside of the workplace didn't seem to take a cardiovascular toll, at least. "Getting into a bad temper at home" was not associated with an increased risk of heart attack or cardiac death, the study authors found.

The findings echo those from a study published last year in the journal Occupational and Environmental Medicine. That study, also from Sweden and involving more than 3,100 men, found that having an overbearing or incompetent boss boosted workers' odds for angina, heart attack and death.

Leineweber stressed that what is true for men might not be true for female workers. While the study included more than 2,000 women, too few of them h
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Imaging cuts in Medicare fee schedule: An access catastrophe and danger to patients
2. For dialysis patients, skinny is dangerous
3. Skiing Not As Dangerous as Believed
4. Hospital Workers May Trigger Dangerous Outbreaks
5. Hanger Orthopedic Group, Inc. Announces Third Quarter 2009 Earnings Release Conference Call
6. Places to play, but stranger danger fears keep inner-city kids home: Study
7. Sport Science Lab Maintains That Injury to USC Football Player is Symptomatic of the Dangers of Conventional Weight Training
8. Clipa for a Cure: New Pink Instant Handbag Hanger Benefits Breast Cancer Research
9. Rural roads dangerous for young drivers
10. Medications That Lower Breast Cancer Risk Carry Other Dangers
11. Scientists Find Clue to Dangerous Side Effect of MS Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... WEDNESDAY, May 23 (HealthDay News) -- The use ... reduced through a multi-pronged approach that includes more ... relatives, according to a new German study. ... ineffective, physical restraints such as bed rails and ... A recent survey found that the rate of ...
(Date:5/23/2012)... Prior treatment with inhaled corticosteroids in patients with ... is associated with a lower incidence and severity ... from researchers in Spain. , A parapneumonic effusion ... that accumulates between the two pleural layers, the ... as a result of a pneumonia, lung abscess, ...
(Date:5/23/2012)... Researchers in the United Kingdom have determined ... anti-inflammatory properties, can be an effective treatment option ... a life-threatening complication that occurs in the majority ... is the leading cause of mortality after the ... when the body repeatedly rejects the transplanted lung ...
(Date:5/22/2012)... Magnetic resonance imaging (MRI) provides an indication ... significantly earlier than possible through clinical examination, according ... journal Radiology . , Women with ... Research has shown that women who receive this ... to achieve breast conservation than those receiving chemotherapy ...
(Date:5/22/2012)... Large randomized controlled trials (RCTs) are critical for ... Yet Canada provides scant support for these studies ... in CMAJ ( Canadian Medical Association ... and Hamilton Health Sciences, Hamilton, Ontario, with Dr. ... the analysis and appendix that Canada should provide ...
Breaking Medicine News(10 mins):Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Canada should significantly increase its funding of randomized clinical trials 2
... company WorldMed Assist says economic downturn has created an uptick in his ... benefit plans that have been dramatically scaled back. , ... Concord, CA ... there were many predictions how this would play out for the young ...
... Dr. Jane L. Delgado, President and CEO ... leading Hispanic health advocacy group, released the following statement ... and Tobacco Control Act, which will provide the Food ... products. "Fifteen years ago Congressman Waxman summoned the ...
... President Obama,s economic stimulus package encourages the use ... this area of healthcare reform to become a reality, ... providers.See video from Siemens (NYSE: SI ) ... Information technology (IT), or the sharing of ...
... fruit, combined with contraceptive pill and a genetic mutation, ... April 2 (HealthDay News) -- A rare set of ... genetic mutation almost cost a 42-year-old woman her leg, ... in the car one afternoon," said Dr. Lucinda Grande, ...
... sports athletesGOLDEN VALLEY, Minn., April 2 ... a history of developing talented, nationally and internationally recognized ... rugby. On Thursday, April 9, at 6 p.m., three ... intent in the Gym at Courage Center Golden Valley. ...
... around us, images flicker into our brains ,like so many ... our eyes move, which is several times a second. Yet ... display. , Why not? , Neuroscientists at The Johns Hopkins ... special region of the brain,s visual cortex ,which is in ...
Other Medicine News:Health News:Economic Turmoil Creates Boom for Medical Tourism 2Health News:Economic Turmoil Creates Boom for Medical Tourism 3Health News:Economic Turmoil Creates Boom for Medical Tourism 4Health News:National Alliance for Hispanic Health Statement on Passage of Bill Granting FDA Authority to Regulate Tobacco 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 3Health News:Courage Center Hosts College Scholarship Signing Ceremony Thursday, April 9, 2009 2Health News:JHU researcher discovers brain cells have 'memory' 2Health News:JHU researcher discovers brain cells have 'memory' 3
(Date:5/23/2012)... Tactile, Inc. (MTI), with the support of The Pre-Mammogram ... developed a pre-commercial SureTouch™ Wireless system that ... According to a publication funded by ... were diagnosed with breast cancer in 2010 and 425,000 ... the best means to a good prognosis for breast ...
(Date:5/23/2012)... 2012   CryoLife, Inc. (NYSE: ... cardiac and vascular surgery, announced today that it will ... One-on-One Investor Conference on Thursday, May 31, 2012 in ... chief operating officer, and chief financial officer of CryoLife, ... conference will allow institutional investors to meet with the ...
(Date:5/23/2012)... 2012 QRxPharma Limited (ASX: QRX and OTCQX: ... Trademark Office (USPTO) issued the Company U.S. Patent No. ... covers a method of treatment of pain comprising the ... compositions of MoxDuo IR (Immediate Release) for the ... (Controlled Release) for the treatment of chronic pain. ...
Breaking Medicine Technology:Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 2Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 3Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 4CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference 2QRxPharma Granted Additional US Patent on MoxDuo® 2QRxPharma Granted Additional US Patent on MoxDuo® 3Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 1Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 1Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 3Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 4Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 5Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 6Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 7Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 1Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 2Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 3Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 4
... NovaDel Pharma,Inc. (AMEX: NVD), a specialty pharmaceutical ... range of marketed treatments,today announced that its ... zolpidem tablets have met their primary,pharmacokinetic (PK), ... currently marketed as Ambien(R), a leading,drug for ...
... Oral Presentation Reports Significantly More Patients ... Least Three,Years, CHICAGO, June 04, 2007 ... (Taxotere plus,prednisone) maintained long-term efficacy as ... cancer patients,according to the three-year updated ...
Other Medicine Technology:NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: